Search hospitals > Tennessee > Memphis
Clinical Neuroscience Solutions, Inc
Claim this profileMemphis, Tennessee 38119
Global Leader in Major Depression
Global Leader in Depression Treatment
Conducts research for Depression
Conducts research for Attention Deficit Hyperactivity Disorder (ADHD)
Conducts research for Attention-Deficit/Hyperactivity Disorder (ADHD)
160 reported clinical trials
3 medical researchers
Summary
Clinical Neuroscience Solutions, Inc is a medical facility located in Memphis, Tennessee. This center is recognized for care of Major Depression, Depression Treatment, Depression, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder (ADHD) and other specialties. Clinical Neuroscience Solutions, Inc is involved with conducting 160 clinical trials across 91 conditions. There are 3 research doctors associated with this hospital, such as Lora McGill, MD, Lisa S Usdan, and Valerie Arnold, MD.Top PIs
Lora McGill, MDCNS Healthcare - Memphis4 years of reported clinical research
Studies Alzheimer's Disease
Studies Migraine
10 reported clinical trials
10 drugs studied
Lisa S UsdanGSK Investigational Site4 years of reported clinical research
Studies Prophylaxis of Respiratory Syncytial Virus Infection
Studies Respiratory Syncytial Virus
5 reported clinical trials
8 drugs studied
Valerie Arnold, MDClinical Neuroscience Solutions, Inc.2 years of reported clinical research
Studies Attention-Deficit/Hyperactivity Disorder (ADHD)
Studies Neonatal Hyperkinesia
5 reported clinical trials
6 drugs studied
Clinical Trials running at Clinical Neuroscience Solutions, Inc
Depression
Alzheimer's Disease
Obesity
Major Depression
Depression Treatment
Alcoholism
Atopic Dermatitis
Attention Deficit Hyperactivity Disorder (ADHD)
Neonatal Hyperkinesia
Attention-Deficit/Hyperactivity Disorder (ADHD)
MM120
for Depression
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Major Depressive Disorder - Emerge
Recruiting2 awards Phase 33 criteria
Azetukalner
for Depression
X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)
Recruiting1 award Phase 35 criteria
SP-624
for Depression
This trial is testing the efficacy of an investigational drug, SP-624 (study drug) to see how well it might work to treat major depressive disorder.
Recruiting0 awards Phase 215 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Clinical Neuroscience Solutions, Inc?
Clinical Neuroscience Solutions, Inc is a medical facility located in Memphis, Tennessee. This center is recognized for care of Major Depression, Depression Treatment, Depression, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder (ADHD) and other specialties. Clinical Neuroscience Solutions, Inc is involved with conducting 160 clinical trials across 91 conditions. There are 3 research doctors associated with this hospital, such as Lora McGill, MD, Lisa S Usdan, and Valerie Arnold, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.